Jane Pan, Executive Director of Hepatitis B Initiative of Washington, D.C. (HBI-DC) was recognized for her advocacy on Wednesday, July 30th, 2014 at the Occidental in Washington, D.C. following World Hepatitis Day at the White House.
Jane continues to raise awareness and save lives by providing the community with free hepatitis B and C testings. Since October of 2009, she has provided Hepatitis B education to 9000+ people and screened over 5700 people where 6.4% tested positive for Hepatitis B. Since 2013, she has also provided Hepatitis C education for 900+ people and screened over 800 where 5% tested positive for Hepatitis C. Thanks to collaborations with the government, community and religious organizations, HBI-DC has been able to provide education, screenings and vaccinations to the Asian, Pacific Islander, African and Hispanic communities. Those who tested positive are linked to care and referred for further evaluation and treatment.
Jane reiterated the importance of collaboration to combat this fight against viral hepatitis in her acceptance speech.” We have work to do. Together we can make a difference!”
Hepatitis B Initiative of Washington, D.C. (HBI-DC) seeks to mobilize communities to prevent liver disease caused by hepatitis B and C among the underrepresented communities. Our goal is to educate the population about viral hepatitis and empower the community with the resources to eradicate the disease. We provide resources that are culturally and linguistically appropriate for each community.
Corporate Hepatitis Alliance
The Corporate Hepatitis Alliance brings together experts in industry to play a more central role in advocating for increased access to quality health care and strengthening infrastructures for the diagnosis and care of people with Viral Hepatitis. Members include: AbbVie, Achillion Pharmaceuticals, Alere, Inc., Biotest Pharmaceuticals Corporation, Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb, Genentech, Gilead Sciences, Inc, GlaxoSmithKline, Health & Medicine Council of Washington, Johnson & Johnson, Kadmon Pharmaceuticals, Merck & Co., OraSure Technologies, Inc.
Educate, Empower and Eradicate
# # #